Dermata Therapeutics's total assets for Q2 2025 were $6.64M, a decrease of -33.63% from the previous quarter. DRMA total liabilities were $1.03M for the fiscal quarter, a -62.04% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.